News

Deeply engaged in plant extraction, connecting with the global market | The 8th Xi'an Natural Health Raw Materials Exhibition Reopens The 24th edition of CPhI & PMEC China 2026, a three-day premier global pharmaceutical ingredients exhibition, concluded successfully at the Shanghai New International Expo Centre.   As an emerging enterprise based in Zitong, Sichuan, specializing in the production of botanical extracts, Justen Biotechnology Co., Ltd. made its debut appearance at this world-class industry event. The company presented over 20 high-purity standardized botanical extract products to global buyers, engaging with clients from Europe, Southeast Asia, the Middle East, and the domestic market. During the exhibition, the company secured intention orders and established numerous collaboration opportunities, achieving three key milestones in its first participation: enhanced brand exposure, expanded client networks, and diversified channel development. About Us: Rooted in Zitong, Dedicated to Botanical Extracts Justen Biotechnology Co., Ltd. is a modern enterprise situated in the Sichuan Zitong Economic Development Zone, specializing in the research, development, production, and marketing of plant-derived extracts. By utilizing cutting-edge technologies like directed separation, the company has built an integrated technical framework covering every stage from raw material sourcing to final product delivery. With precise regulation of extraction parameters and intelligent manufacturing systems, it ensures high purity and excellent batch-to-batch reproducibility across over 20 botanical products, such as soybean isoflavones, sophoricoside, genistein, resveratrol, and polygonum multiflorum glycoside, capable of meeting the most rigorous demands of both pharmaceutical-grade and food-grade applications.  Qualification Certification: Quality-oriented, Standards-driven Qualification Certification Matrix: Compliance comes first. Comprehensive quality control is the core strength that enables products to enter the global market. It stems from a complete and well-established set of qualifications and strict testing systems; Source material control: Cooperate with GAP standardized planting bases, establish a complete source material traceability ledger, provide non-GMO certification, and ensure that the raw materials are natural and free from pesticide residues from the source; International Export Certification: Complete set of FDA registration, KOSHER Jewish kosher certification, HALAL Halal certification, NON-GMO non-genetically modified certification, compliant with the entry standards of multiple countries in Europe, America and the Middle East. Standardized quality control laboratory: Equipped with HPLC (high performance liquid chromatography), UV (ultraviolet) detector, and a microbiological sterility testing room. For each batch of products, a complete COA (certificate of analysis) test report is issued, strictly controlling the four core indicators of activity content, heavy metals, solvent residues, and microorganisms; Production compliance qualifications: Hold the food SC production license and follow the HACCP and FSSC22000 food safety management standards for production. Core product: Three series, complete chain layout At this CPHI exhibition, we showcased three major advantageous product lines: high purity, stable supply, and customizable specifications. These features were highly recognized by overseas and domestic buyers: The soy isoflavone series are the core raw materials of natural plant estrogens. Various content specifications are available for selection. They are widely used in functional health products, female dietary supplements, and pharmaceutical preparations. Relying on high-quality soy raw materials from the Sichuan-Chongqing region, the extracted products have high activity and low impurities, and the supply is stable over the long term. Huali Jiao extract (Huali Jiao glycoside, catechuin) is the company's flagship product with significant advantages. It is suitable for cardiovascular and cerebrovascular preparations as well as dietary health foods. The company can provide customized high-purity monomers with extremely low batch-to-batch variations, and is highly favored by domestic pharmaceutical factories and foreign trade traders. Polygonum extract (resveratrol) is a popular natural antioxidant raw material covering multiple fields such as food, cosmetics and medicine. The regular inventory is sufficient and flexible orders of various sizes are supported. At the same time, small and high-value-added monomer extracts like astragaloside and rehmanniin are also exhibited on-site to meet the diversified formula development needs of customers. Next stop: The Shanghai exhibition of the 2026 WPE Natural Health Raw Materials Expo in Xi'an comes to an end. The journey of cooperation continues without pause! On August 24th - 26th, 2026, the WPE & WHPE 2026 World Expo of Natural Health Raw Materials is held at the Xi'an International Convention and Exhibition Center. As the core gathering area of the national plant extract industry, Xi'an has nearly 2,000 upstream and downstream enterprises, a complete supply chain, a large number of precise buyers, and multiple industry-leading forums. It is an excellent platform for expanding the domestic northwest market and connecting with foreign trade channels in the second half of the year. 2026 WPE&WHPE Looking ahead: In August 2026, we'll meet again in Xi'an Natural Health Raw Materials World Expo Exhibition Name: WPE & WHPE Event Dates: August 24-26, 2026 Exhibition hall address: Xi'an International Convention and Exhibition Center. Booth number: 1G-03 At that time, we will present our upgraded product system, additional high-purity monomer samples, and improved production capacity plans at the exhibition booth. We sincerely invite both new and existing purchasing customers as well as raw material suppliers to visit Booth 1G-03. Come and negotiate sample trials, bulk purchases, and long-term cooperation on-site!

From June 24th to 26th, Sichuan Zidali Biotechnology Co., Ltd., as a leading manufacturer and technological innovator of plant estrogen products, made its debut at the 23rd World Pharmaceutical Raw Materials China Exhibition and the 18th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition held at the Shanghai New International Expo Center in 2025. This grand event attracted more than 15000 overseas visitors from 166 countries and regions around the world to register, providing a broad platform for communication and cooperation in the pharmaceutical industry. ​ As a high-tech enterprise dedicated to the research and development, production, and sales of plant estrogen products, Zidali Biotechnology is committed to becoming the largest plant estrogen product manufacturer and technology innovation center in China. At this exhibition, the company showcased its comprehensive business system and won the attention of many attendees for its mature industrial chain from production to trade. The company's flagship products - soybean extract, Sophora japonica extract, Polygonum multiflorum extract, grapefruit extract, Sculcap extract, Polygonum cuspidatum extract, Houttuynia cordata extract, Fructus Aurantii extract and other plant extracts - have become the focus of the natural extract exhibition area with their excellent quality and leading extraction technology. These products not only occupy an important position in the domestic market, but are also exported overseas, providing high-quality raw material support for the global health industry. ​ In addition, Zidali Biotechnology actively expanded its new product development matrix and showcased new products such as red clover and flaxseed extract for the first time at the exhibition. The company's R&D team stated that these new products are developed based on in-depth research on market trends and precise grasp of consumer health needs, which will further enrich the company's product system and meet the diverse needs of different customers. ​ During the exhibition, the booth of Zidali Biotechnology attracted a large number of domestic and foreign professional visitors to stop and exchange ideas. The company has reached preliminary cooperation intentions with potential customers from multiple countries and regions such as India, South Korea, and Pakistan, further promoting the internationalization process of the company's products. At the same time, the company has also had in-depth exchanges with many well-known pharmaceutical companies and research institutions in China, laying a solid foundation for future industry university research cooperation. ​ The person in charge of Sichuan Zidali Biotechnology Co., Ltd. stated that this exhibition is an important opportunity for the company to showcase its strength, expand its market, and strengthen communication. By participating in this international event, the company not only showcased the leading level of Chinese plant estrogen products to the world, but also injected new impetus into its own development. In the future, the company will continue to increase research and development investment, constantly innovate, improve product quality and service level, and contribute more to the development of the global health industry. ​ With the continuous promotion of the World Pharmaceutical Raw Materials China Exhibition and the World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition, Sichuan Zidali Biotechnology Co., Ltd. is expected to achieve more results on this international stage, helping China's pharmaceutical industry occupy a more important position in the global industrial chain. ​ Standardized Plant Extract,Plant Extract,Soybean Extract,Standardized Extract.

Recently, industry data and related feedback have shown that the export of plant extracts in the global market is showing strong growth momentum. As consumers' attention to natural and healthy products continues to increase, the market demand for plant-based extracts as core raw materials in industries such as food, medicine, and cosmetics continues to rise. ​ Statistical data shows that in the past year, the export volume of plant extracts in China has significantly increased, reaching over 100 million yuan, setting a new historical high. Traditional markets such as the United States, Japan, and the European Union remain the main sources of demand, while emerging markets such as Southeast Asia and the Middle East are also showing a rapid growth trend in demand for plant extracts. The export volume and value of categories such as menthol, stevia extract, and citrus essential oil have all achieved significant growth. ​ From the perspective of regional development, Shaanxi, as a major province in the plant extract industry, has shown impressive performance in export growth. From January to April, Shaanxi exported 5342 tons of plant extracts, a year-on-year increase of 40.2%, with a value of 698 million yuan, a year-on-year increase of 26.1%. New export breakthroughs are also emerging in other regions, such as the first export of honeysuckle extract in a certain region, and the successful export of siraitia grosvenorii extract in a certain region to the United States, promoting the new development of local "rural foreign trade"; The shiitake mushroom extract from certain regions has been successfully exported overseas, with over a hundred types of local extract products exported and markets covering nearly 40 countries and regions. ​ Relevant departments in various regions actively assist enterprises in exporting. For example, some customs carry out lectures on international trade inspection and quarantine requirements to help enterprises improve their management level; Implement refined management of exported plant extracts according to different uses to avoid unreasonable cost increases; Simplify the registration and approval procedures for export production enterprises, promote the "cloud issuance" of inspection and quarantine certificates, and significantly shorten the business processing time. In addition, local commerce departments actively coordinate multiple departments to solve export problems for enterprises. ​ Industry insiders analyze that the growth in exports of plant extracts is mainly due to the popularization of global health consumption concepts and the widespread use of natural and green raw materials in various industries. At the same time, technological progress has driven the continuous improvement of extraction processes and quality standards, further enhancing the competitiveness of Chinese products in the international market. However, the development of the industry also faces challenges, with significant differences in extraction standards and regulations among different countries and regions. Companies need to invest more effort in addressing compliance issues, and fluctuations in raw material prices also have an impact on cost control and profit margins. ​ Looking ahead to the future, as the demand for plant extracts continues to grow in the global market, Chinese companies are expected to further expand their international market share. However, enterprises still need to increase research and development investment, improve product quality and technological content, closely monitor changes in international regulations and standards, actively respond to market risks, and achieve sustainable development. ​ Concentrated Extract,Cinnamomum Burmannii Bark Extract,Dandelion Root Extract,Grapefruit Extract.